Cite
HARVARD Citation
Cao, C. et al. (2021). A CRISPR/dCasX‐mediated transcriptional programming system for inhibiting the progression of bladder cancer cells by repressing c‐MYC or activating TP53. Clinical and translational medicine. 11 (9), p. n/a. [Online].